EZH2 and cancer: In vitro overexpression of EZH2 in cancer cell lines has been shown to activate their proliferation, migration, and invasion abilities.2 In contrast, knockdown of EZH2 using siRNA or shRNA results in cell growth inhibition and suppression of oncogenic capacity[2].